4//SEC Filing
Bair Teresa Brophy 4
Accession 0000950170-24-062585
CIK 0001422143other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 6:30 PM ET
Size
5.6 KB
Accession
0000950170-24-062585
Insider Transaction Report
Form 4
Bair Teresa Brophy
Chief Legal Officer
Transactions
- Sale
Common Stock
2024-05-20$22.15/sh−2,615$57,916→ 68,979 total
Footnotes (4)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2023.
- [F2]2615 shares were acquired on May 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F3]This transaction was executed in multiple trades at prices ranging from $22.06 to $22.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]The reported sale of 2,615 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2023.
Documents
Issuer
Kura Oncology, Inc.
CIK 0001422143
Entity typeother
Related Parties
1- filerCIK 0001813058
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 6:30 PM ET
- Size
- 5.6 KB